10-87864539-G-C
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000314.8(PTEN):c.70G>C(p.Asp24His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,686 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D24G) has been classified as Pathogenic.
Frequency
Consequence
NM_000314.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTEN | NM_000314.8 | c.70G>C | p.Asp24His | missense_variant | Exon 1 of 9 | ENST00000371953.8 | NP_000305.3 | |
PTEN | NM_001304717.5 | c.589G>C | p.Asp197His | missense_variant | Exon 2 of 10 | NP_001291646.4 | ||
PTEN | NM_001304718.2 | c.-636G>C | 5_prime_UTR_variant | Exon 1 of 9 | NP_001291647.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461686Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 727174
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Pathogenic:1
- -
Cowden syndrome 1 Pathogenic:1
- -
PTEN hamartoma tumor syndrome Pathogenic:1
This variant disrupts the p.Asp24 amino acid residue in PTEN. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 21194675, 22503188). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. This sequence change replaces aspartic acid, which is acidic and polar, with histidine, which is basic and polar, at codon 24 of the PTEN protein (p.Asp24His). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with clinical features consistent with PTEN hamartoma tumor syndrome and/or PTEN-related conditions (PMID: 21194675, 24778394, 34308366; Invitae). ClinVar contains an entry for this variant (Variation ID: 186005). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PTEN protein function. Experimental studies have shown that this missense change affects PTEN function (PMID: 29706633). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
not provided Pathogenic:1
Reported in individuals with features of PTEN Hamartoma Tumor syndrome, including one apparently de novo observation (PMID: 34308366, 34374989, 22381246); Published functional studies demonstrate a damaging effect: impaired lipid phosphatase activity, aberrant cellular localization (PMID: 29706633, 29706350); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30626916, 21194675, 24778394, 33138866, 22381246, 23764071, 25669429, 24475377, 36453251, 29706633, 34308366, 34374989, 29706350) -
Glioma Pathogenic:1
PM6,PM3(strong),PM2,PP3,PM5 -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.D24H pathogenic mutation (also known as c.70G>C), located in coding exon 1 of the PTEN gene, results from a G to C substitution at nucleotide position 70. The aspartic acid at codon 24 is replaced by histidine, an amino acid with similar properties. This mutation has been identified in two separate females with the following similar Cowden syndrome/PHTS characteristics: pathognomonic dermatological features, breast cancer, uterine cancer, macrocephaly, multinodular goiter, and renal cell carcinoma (Mester JL, Urology 2012 May; 79(5):1187.e1-7; Shuch B, J. Urol. 2013 Dec; 190(6):1990-8). This mutation was also found in multiple individuals meeting clinical criteria for Cowden Syndrome (Tan MH, Am. J. Hum. Genet. 2011 Jan; 88(1):42-56; Ngeow J et al. J. Clin. Oncol., 2014 Jun;32:1818-2; Nizialek EA et al. Eur. J. Hum. Genet., 2015 Nov;23:1538-43). Further, an additional disease-causing mutation, p.D24N, has been described at this same codon. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
Ovarian neoplasm Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at